Evidence map›Paper›PMID 26557109›Full record

ReviewFrontiers in microbiology2015

Controlling of CSFV in European wild boar using oral vaccination: a review.

Sophie Rossi, Christoph Staubach, Sandra Blome, Vittorio Guberti, Hans-Hermann Thulke, Ad Vos, Frank Koenen, Marie-Frédérique Le Potier

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 132 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Exploring the Genetic Basis of Wild Boar (Transboundary and emerging diseases · 2025
    Article
  14. Article
  15. Article
  16. Use of Chemical Tracers inAnimals : an open access journal from MDPI · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Sophie RossiUnité Sanitaire de la Faune, Office National de la Chasse et de la Faune Sauvage Gap, France.
Christoph StaubachFriedrich-Loeffler-Institut, Federal Research Institute for Animal Health Greifswald, Germany.
Sandra BlomeFriedrich-Loeffler-Institut, Federal Research Institute for Animal Health Greifswald, Germany.
Vittorio GubertiInstituto Superiore per la Protezione e la Ricerca Ambientale Ozzano dell'Emilia, Italy.
Hans-Hermann ThulkeDepartment of Ecological Modelling, Helmholtz Centre for Environmental Research-UFZ Leipzig, Germany.
Ad VosDevelopment Vaccines Technologies, IDT Biologika GmbH Dessau-Rosslau, Germany.
Frank KoenenOperational Direction Interactions and Surveillance, Centrum voor Onderzoek in Diergeneeskunde en Agrochemie-Centre d'Etude et de Recherches Vétérinaires et Agrochimiques Ukkel, Belgium.
Marie-Frédérique Le PotierLaboratoire de Ploufragan/Plouzané, Unité Virologie Immunologie Porcines, Anses Ploufragan, France.
Friedrich-Loeffler-Institut · DEHelmholtz Centre for Environmental Research · DEIDT Biologika (Germany) · DEIstituto Superiore per la Protezione e la Ricerca Ambientale · ITOffice National de la Chasse et de la Faune Sauvage · FRVeterinary and Agrochemical Research Centre · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Classical swine fever (CSF) is among the most detrimental diseases for the swine industry worldwide. Infected wild boar populations can play a crucial role in CSF epidemiology and controlling wild reservoirs is of utmost importance for preventing domestic outbreaks. Oral mass vaccination (OMV) has been implemented to control CSF in wild boars and limit the spill over to domestic pigs. This retrospective overview of vaccination experiences illustrates the potential for that option. The C-strain live vaccine was confirmed to be highly efficacious and palatable baits were developed for oral delivery in free ranging wild boars. The first field trials were performed in Germany in the 1990's and allowed deploying oral baits at a large scale. The delivery process was further improved during the 2000's among different European countries. Optimal deployment has to be early regarding disease emergence and correctly designed regarding the landscape structure and the natural food sources that can compete with oral baits. OMV deployment is also highly dependent on a local veterinary support working closely with hunters, wildlife and forestry agencies. Vaccination has been the most efficient strategy for CSF control in free ranging wild boar when vaccination is wide spread and lasting for a sufficient period of time. Alternative disease control strategies such as intensified hunting or creating physical boundaries such as fences have been, in contrast, seldom satisfactory and reliable. However, monitoring outbreaks has been challenging during and after vaccination deployment since OMV results in a low probability to detect virus-positive animals and the live-vaccine currently available does not allow serological differentiation of infected from vaccinated animals. The development of a new marker vaccine and companion test is thus a promising option for better monitoring outbreaks during OMV deployment as well as help to better determine when to stop vaccination efforts. After rabies in red fox, the use of OMV against CSF in European wild boar can be considered as a second example of successful disease control in wildlife. The 30 years of disease control experience included in this review may provide options for improving future disease management within wild populations.

Indexed as

diseasesmanagementPestivirussurveillanceSus scrofawildlife

Identifiers

PMID26557109
PMCPMC4615961
OpenAlexW2158119890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.